News
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...
Objective Paraneoplastic optic neuropathy (PON) is relatively uncommon, and the visual outcomes and prognosis of this disease have not been well documented. The aim of this study was to investigate ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...
Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged retinal tissue. It offers a gentle, biocompatible way to stabilize the inner ...
The specific condition was non-arteritic anterior ischemic optic neuropathy. "That can cause this sudden and permanent vision loss, usually in just one eye. Now, I should be clear this isn't total ...
The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...
Another area where this ICH guideline interfaces with prior ischemic stroke guidelines is the challenging area of antithrombotic agent use in patients after ICH who are at risk for both recurrent ICH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results